These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10513638)

  • 1. Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users.
    Gibson DR; Flynn NM; McCarthy JJ
    AIDS; 1999 Oct; 13(14):1807-18. PubMed ID: 10513638
    [No Abstract]   [Full Text] [Related]  

  • 2. [Does methadone lessen HIV risk behavior?].
    Mader U
    Dtsch Med Wochenschr; 1997 Feb; 122(8):A7-8. PubMed ID: 9081808
    [No Abstract]   [Full Text] [Related]  

  • 3. Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection.
    Gowing LR; Farrell M; Bornemann R; Sullivan LE; Ali RL
    J Gen Intern Med; 2006 Feb; 21(2):193-5. PubMed ID: 16336624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of syphilis and HIV infection among injection drug users receiving methadone in the Bronx, NY.
    Gourevitch MN; Hartel D; Schoenbaum EE; Selwyn PA; Davenny K; Friedland GH; Klein RS
    Am J Public Health; 1996 Aug; 86(8):1112-5. PubMed ID: 8712270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in HIV risk behaviour and methadone dosage among HIV-negative drug users: an ecological study.
    Langendam MW; van Brussel GH; Coutinho RA; van Ameijden EJ
    AIDS; 2000 Aug; 14(12):1870-2. PubMed ID: 10985334
    [No Abstract]   [Full Text] [Related]  

  • 6. [Risk behaviours among intravenous drug users under methadone treatment].
    Pérez K; Rodés A; Meroño M; Casabona J
    Med Clin (Barc); 2001 Mar; 116(8):315-6. PubMed ID: 11333755
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV infection as a predictor of methadone maintenance outcomes in Chinese injection drug users.
    Zhao L; Holzemer WL; Johnson M; Tulsky JP; Rose CD
    AIDS Care; 2012; 24(2):195-203. PubMed ID: 21780984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
    Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
    Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin.
    Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
    J Epidemiol Community Health; 1996 Oct; 50(5):534-7. PubMed ID: 8944860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study.
    Serpelloni G; Carrieri MP; Rezza G; Morganti S; Gomma M; Binkin N
    AIDS Care; 1994; 6(2):215-20. PubMed ID: 8061081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone maintenance and cessation of injecting drug use: results from the Amsterdam Cohort Study.
    Langendam MW; van Brussel GH; Coutinho RA; van Ameijden EJ
    Addiction; 2000 Apr; 95(4):591-600. PubMed ID: 10829334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of methadone maintenance treatment for HIV-positive drug users in Vietnam.
    Tran BX; Ohinmaa A; Duong AT; Do NT; Nguyen LT; Mills S; Houston S; Jacobs P
    AIDS Care; 2012; 24(3):283-90. PubMed ID: 21936718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy for drug users.
    Clarke SM; Mulcahy FM
    Int J STD AIDS; 2000 Oct; 11(10):627-31. PubMed ID: 11057932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Health related quality of life among HIV-HCV co-infected patients].
    Préau M; Protopopescu C; Spire B; Dellamonica P; Poizot-Martin I; Villes V; Carrieri MP;
    Rev Epidemiol Sante Publique; 2006 Jul; 54 Spec No 1():1S33-1S43. PubMed ID: 17073128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Methadone. Reducing the transmission of HIV].
    Sabourin G
    Perspect Infirm; 2013; 10(3):56. PubMed ID: 23705283
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV infection and AIDS risk behaviors among injecting drug users entering methadone treatment: an update.
    Battjes RJ; Pickens RW; Brown LS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):90-6. PubMed ID: 7648291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation pattern of methadone users and its association with social connection and HIV status: Analyses of electronic health records data.
    Kwan TH; Wong NS; Lee SS
    PLoS One; 2019; 14(5):e0216727. PubMed ID: 31071182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users.
    Williams AB; McNelly EA; Williams AE; D'Aquila RT
    AIDS Care; 1992; 4(1):35-41. PubMed ID: 1314099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Special problems of HIV-positive women who are either drug abusers or on methadone replacement therapy].
    Isernhagen K
    Zentralbl Gynakol; 1999; 121(11):555-7. PubMed ID: 10612228
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of low-threshold methadone maintenance therapy for people who inject drugs on HIV incidence in Vancouver, BC, Canada: an observational cohort study.
    Ahamad K; Hayashi K; Nguyen P; Dobrer S; Kerr T; Schütz CG; Montaner JS; Wood E
    Lancet HIV; 2015 Oct; 2(10):e445-50. PubMed ID: 26423652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.